Achieving Portal Access With Scorpion Post-Approval Study 2

计划入组 82 人 · 首次发布于 2025 年 3 月 4 日

Achieving Portal Access With Scorpion Post-Approval Study (APASS)

计划入组 3 人 · 首次发布于 2023 年 3 月 13 日

Does Access to an EHR Patient Portal Influence Chronic Disease Outcomes?

计划入组 6,000 人 · 首次发布于 2005 年 9 月 7 日

AP-2011

INC-104

INC-101

Portal Therapeutics, Inc.

United States

Access Vascular, Inc.

United States

CLINTON HEALTH ACCESS INITIATIVE INC.

Malaysia

Portal Access Secures $7M Series A to Advance Next-Generation Chemotherapy Port Through FDA Approval

FDA Approves Expanded Access Program for Ocugen's OCU400 in Retinitis Pigmentosa

Profusa Partners with NVIDIA to Develop AI-Powered Continuous Biomarker Monitoring Portal